Back to Search
WILLIAM SHIPLEY, DMD
DMD
General Practice Dentistry
NPI: 1982797403Individual
Specialties, Licenses & Credentials
General Practice DentistryPrimary
Dentist — General Practice
Code: 1223G0001X
6653(KY)
Research & Publications (20)
Phase I-II RTOG study (99-06) of patients with muscle-invasive bladder cancer undergoing transurethral surgery, paclitaxel, cisplatin, and twice-daily radiotherapy followed by selective bladder preservation or radical cystectomy and adjuvant chemotherapy.
PMID 19100600·Urology·2009
3-trial
Variation in the definition of clinical target volumes for pelvic nodal conformal radiation therapy for prostate cancer.
PMID 18947941·Int J Radiat Oncol Biol Phys·2009
4-observational
Potential surrogate endpoints for prostate cancer survival: analysis of a phase III randomized trial.
PMID 19211454·J Natl Cancer Inst·2009
3-trial
Surgery: selective bladder-preserving therapy for muscle-invasive cancer.
PMID 19333224·Nat Rev Clin Oncol·2009
8-other
The results of concurrent chemo-radiotherapy for recurrence after treatment with bacillus Calmette-Guérin for non-muscle-invasive bladder cancer: is immediate cystectomy always necessary?
PMID 19154448·BJU Int·2009
8-other
Cardiovascular mortality after androgen deprivation therapy for locally advanced prostate cancer: RTOG 85-31.
PMID 19047297·J Clin Oncol·2009
3-trial
Late pelvic toxicity after bladder-sparing therapy in patients with invasive bladder cancer: RTOG 89-03, 95-06, 97-06, 99-06.
PMID 19636019·J Clin Oncol·2009
3-trial
Prognostic value of survivin in locally advanced prostate cancer: study based on RTOG 8610.
PMID 18977097·Int J Radiat Oncol Biol Phys·2009
8-other
Celebrating 40 years of clinical inquiry: The RTOG'S ruby anniversary.
PMID 18474307·Int J Radiat Oncol Biol Phys·2008
8-other
Diabetes and mortality in men with locally advanced prostate cancer: RTOG 92-02.
PMID 18779620·J Clin Oncol·2008
2-rct
Structure and functional role of dynein's microtubule-binding domain.
PMID 19074350·Science·2008
7-preclinical
Ten-year follow-up of radiation therapy oncology group protocol 92-02: a phase III trial of the duration of elective androgen deprivation in locally advanced prostate cancer.
PMID 18413638·J Clin Oncol·2008
3-trial
Newer imaging modalities to assist with target localization in the radiation treatment of prostate cancer and possible lymph node metastases.
PMID 18406936·Int J Radiat Oncol Biol Phys·2008
6-review
Does timing of androgen deprivation influence radiation-induced toxicity? A secondary analysis of radiation therapy oncology group protocol 9413.
PMID 18314175·Urology·2008
8-other
Bladder preservation: optimizing radiotherapy and integrated treatment strategies.
PMID 19035903·BJU Int·2008
6-review
Cardiovascular mortality and duration of androgen deprivation for locally advanced prostate cancer: analysis of RTOG 92-02.
PMID 18243498·Eur Urol·2008
2-rct
Long-term treatment sequelae after external beam irradiation with or without hormonal manipulation for adenocarcinoma of the prostate: analysis of radiation therapy oncology group studies 85-31, 86-10, and 92-02.
PMID 17881145·Int J Radiat Oncol Biol Phys·2008
3-trial
COX-2 expression predicts prostate-cancer outcome: analysis of data from the RTOG 92-02 trial.
PMID 17881290·Lancet Oncol·2007
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 9900 OLD THIRD STREET ROAD
LOUISVILLE, KY 40272 - Phone
- (502) 933-2228
Quick Facts
- NPI
- 1982797403
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile